DK107742C - Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf. - Google Patents

Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf.

Info

Publication number
DK107742C
DK107742C DK102763A DK102763A DK107742C DK 107742 C DK107742 C DK 107742C DK 102763 A DK102763 A DK 102763A DK 102763 A DK102763 A DK 102763A DK 107742 C DK107742 C DK 107742C
Authority
DK
Denmark
Prior art keywords
tetrahydroindane
carboxyethyl
oxo
hydroxy
esters
Prior art date
Application number
DK102763A
Other languages
Danish (da)
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK107742C publication Critical patent/DK107742C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/80Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
    • C07C59/82Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/38Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J61/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DK102763A 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf. DK107742C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR890184A FR1364556A (fr) 1962-03-06 1962-03-06 Nouveau procédé de synthèse de stéroïdes et de composés apparentés et produits utilisés dans ce procédé

Publications (1)

Publication Number Publication Date
DK107742C true DK107742C (da) 1967-07-03

Family

ID=8774160

Family Applications (1)

Application Number Title Priority Date Filing Date
DK102763A DK107742C (da) 1962-03-06 1963-03-06 Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf.

Country Status (5)

Country Link
AT (6) AT253693B (de)
DE (1) DE1290937B (de)
DK (1) DK107742C (de)
ES (1) ES285708A1 (de)
FR (1) FR1364556A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1446408A (fr) * 1965-06-09 1966-07-22 Roussel Uclaf Nouveau procédé de préparation de certains dérivés de l'indane
FR1506347A (fr) * 1966-07-27 1967-12-22 Roussel Uclaf Nouveaux composés optiquement actifs, de structure bicyclique, et procédé de préparation
US3897460A (en) * 1968-10-04 1975-07-29 Hoffmann La Roche 3{62 -Tertiarybutoxy-decahydro-benz{8 E{9 indenes
CA977351A (en) * 1968-10-04 1975-11-04 Zoltan G. Hajos Tricyclic compounds and their manufacture

Also Published As

Publication number Publication date
ES285708A1 (es) 1963-06-01
FR1364556A (fr) 1964-06-26
AT253690B (de) 1967-04-25
AT253693B (de) 1967-04-25
AT253691B (de) 1967-04-25
AT258484B (de) 1967-11-27
AT253692B (de) 1967-04-25
DE1290937B (de) 1969-03-20
AT266345B (de) 1968-11-11

Similar Documents

Publication Publication Date Title
DK114131B (da) Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7αβ-methyl-3aα,4β,5,6,7,7a-hexahydroindan eller acylderivater deraf.
DK114840B (da) Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf.
DK104232C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ<4,9,11>-estratrien eller dets estere.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK107742C (da) Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf.
DK115916B (da) Fremgangsmåde til fremstilling af 1-(2'-desoxy-D-ribofuranosyl)-5-fluor-cytosiner eller 4-N-p-toluoylderivater deraf.
DK103610C (da) Fremgangsmåde til fremstilling af 7-chlor-4,6,2'-trimethoxy-6'-methyl-gris-2'-en-4'-ol-3-on eller estere deraf.
DK111447B (da) Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on.
DK127598B (da) Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf.
DK127507B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK104303C (da) Fremgangsmåde til fremstilling af 3α-hydroxy-11-oxo-21,21-bis-(hydroxymethyl)-5β-pregnan eller estere deraf.
DK102858C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-10β-allyl-Δ<4,9(11)>-estradien eller dets estere.
DK110052C (da) Fremgangsmåde til fremstilling af 2,3,4-trimethoxy-5-(2'-carboxyethyl)-8,9-dihydro-7H-benzocyclohepten eller estere heraf.
DK103239C (da) Fremgangsmåde til fremstilling af 2,3-dicyan-1,4-dithia-anthrahydroquinon eller 2,3-dicyan-1,4-dithia-anthraquinon.
DK114831B (da) Fremgangsmåde til fremstilling af hjertevirksomme 4'-acylcymariner.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK107296C (da) Fremgangsmåde til fremstilling af basiske 3,5-dimenthoxy-4-alkoxybenzoesyreestere.
DK99142C (da) Fremgangsmåde til fremstilling af 6,16α-dialkyl-17α-hydroksy-6-dehydro-progesteron eller estere deraf.
DK104170C (da) Fremgangsmåde til fremstilling af 3-alkoxy- eller 3-aralkoxy-16-amino-Δ<3,5>-pregnadien-17α-ol-20-oner, eller 16-amino-Δ<4>-pregnen-17α-ol-3,20-dioner.
DK105112C (da) Fremgangsmåde til fremstilling af 2-carbonhydridsubstituerede 17-oxygenerede-A-nor-5α-androstan-2-oler eller estere deraf.
DK106091C (da) Fremgangsmåde til fremstilling af 17α-alkyl-17β-hydroxy-2-azaandrostan-3-oner eller 17α-alkyl-17β-hydroxy-3-aza-A-homoandrostan-4-oner.
DK106670C (da) Fremgangsmåde til fremstilling af Δ<3>-17β-hydroxy-17α-methyl-5α-androsten eller estere deraf.
DK105868C (da) Fremgangsmåde til fremstilling af Δ<4>-3-keto-6α-alkyl-19-nor-pregnener eller estere deraf.
DK107555C (da) Fremgangsmåde til fremstilling af 1,4-benzo-diazepin-4-oxider eller syreadditionssalte deraf.